Sangamo Therapeutics, Inc.
OTCPKSGMO cost to borrow soars 181.7% in one week to 0.75%, signaling tight borrow conditions for the troubled gene-therapy stock.
Snapshot as of 7 May 2026
Sangamo Therapeutics approaches its May 7 earnings release with short sellers firmly in control of the tape — and a stock that has lost 41% in a month to trade at $0.18. Short interest tells the dominant story into…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SGMO — free to start on ORTEX.
Sign up for free →Open SGMO on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live SGMO data →